JW Asset Management is an SEC-registered investment adviser founded in 1998 by Jason Wild, based in New York City. The firm invests across public and private equity with a focus on healthcare, specialty pharmaceuticals, and cannabis, managing over $1B in assets under management.
Their most common stage is series-a (54% of deals). Average disclosed round size is $17.0M (across 11 rounds with reported amounts).
Portfolio
10
Fund Size
$1B
Top Stage
Series A
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
13 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Pistil Data | Seed | $6.5M | Nov 2021 |
| FFyllo | Series C | $40M | Nov 2021 |
| CCityrow Go | Series A | $12M | Jul 2021 |
 CityRow | Series A | $12M | Jul 2021 |
| FFyllo | Series A | $10M | Aug 2020 |
| FFyllo | Series A | $10M | Jan 2020 |
| CCanndescent | Series C | $27.5M | Sep 2019 |
 Henry's Original | Series B | $11M | Aug 2019 |
| VVitruvias Therapeutics | Series A | $11.5M | Jan 2018 |
 Arbor Pharmaceuticals | Series B | $34.8M | Nov 2010 |
 Vensun Pharmaceuticals | Series B | — | — |
| Vensun Pharmaceuticals | Series A | — | — |
 Vitruvias | Series A | $11.5M | — |
Top Co-Investors
Perceptive Advisors4 shared
Phyto Partners2 shared
India Quotient2 shared
K2 Global2 shared
SOL Global Investments Corp.2 shared
Leo Capital2 shared
ArrowMark Partners1 shared
Ardian1 shared
Casa Verde Capital1 shared
Merida Capital Holdings1 shared
Delta Emerald Ventures1 shared
Signet Healthcare Partners1 shared
Last updated: 8 September 2026